Estela Pineda
Medical Oncology Department OncologyResearch group
- Translational genomics and targeted therapies in solid tumours Accredited researcher (R3A)
Featured publications
-
Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis
Authors:Reference: Annals Of Oncology 2023. -
Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy
Authors:Reference: Clinical Cancer Research 2020. -
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01)
Authors:Reference: Neuro-Oncology 2020. -
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
Authors:Reference: Targeted Oncology 2020. -
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study
Authors:Reference: Esmo Open 2020. -
MET inhibitors in cancer: pitfalls and challenges
Authors:Reference: Expert Opinion On Investigational Drugs 2020. -
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
Authors:Reference: Nature Communications 2019. -
Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.
Authors:Reference: Journal Of Clinical Oncology 2019. -
COULD SUSPECTED GLIOBLASTOMAS BE TREATED WITHOUT HYSTOLOGICAL DIAGNOSIS?
Authors:Reference: Neuro-Oncology 2019. -
Predictive serum biomarkers in metastatic colorectal cancer patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (GEMCAD 09-01)
Authors:Reference: European Journal Of Cancer 2015.